|
|
咗他莫司市场分析报告
|
Zotarolimus (CAS 221877-54-9) Market Research Report 2025
BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Zotarolimus Market Research Report 2025
BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Global Market Report of ZOTAROLIMUS (CAS 221877-54-9)
December 2024
Drug-Eluting Stents Market Report by Coating (Polymer Based Coating, Polymer Free Coating), Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, and Others), Stent Platform (Stainless-steel, Cobalt-Chromium, Platinum-Chromium, Nitinol, and Others), Generation (1st Generation, 2nd Generation, 3rd Generation, 4th Generation), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region ?2025-2033?
... Coating Breakup by Drug: Sirolimus Paclitaxel Zotarolimus Everolimus Biolimus Others Breakup by Stent ...
Coronary Drug Eluting Stent Market - Distribution by Type of Drug Eluted (Sirolimus, Paclitaxel, Everolimus, Zotarolimus and Others), Stent Material (Platinum Chromium, Cobalt Chromium, Stainless Steel and Others) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
... of Drug Eluted Sirolimus Paclitaxel Everolimus Zotarolimus Others Stent Material Platinum Chromium ...
Chunghwa Chemical Synthesis & Biotech Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
... , tacrolimus, everolimus, mycophenolate mofetil HCL, zotarolimus, biolimus, temsirolimus, mycophenolate sodium, and ...
Global Drug Coated Stent Market Growth 2023-2029
... : Segmentation by type Everolimus-Coated Stent Zotarolimus-Coated Stent Ridaforolimus-Coated Stent ...
Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... Coating Breakup by Drug: Sirolimus Paclitaxel Zotarolimus Everolimus Biolimus Others Breakup by Stent ...
Global Drug Coated Stent Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... segment by Type Everolimus-Coated Stent Zotarolimus-Coated Stent Ridaforolimus-Coated Stent ...
Drug Coated Stent Market, Global Outlook and Forecast 2022-2028
... , by Type, 2021 (%) Everolimus-Coated Stent Zotarolimus-Coated Stent Ridaforolimus-Coated Stent ...
Interventional Cardiology: Market Research Report
This report analyzes the worldwide markets for Interventional Cardiology in US$ Million. The market for Interventional Cardiology Devices is analyzed by the following product segments: Coronary Stents, Peripheral Devices, Angioplasty Catheters, ...
Coronary Stents Market Market Insights, Competitive Landscape and Market Forecast–2026
... (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE ...
Global Drug Coated Stent Market Research Report 2025(Status and Outlook)
... Segmentation (by Type) Everolimus-Coated Stent Zotarolimus-Coated Stent Ridaforolimus-Coated Stent ...
Intravascular Stents Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), By Product (Coronary Stents, Peripheral Stents), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2019-2029F
... various drug types (e.g., sirolimus, paclitaxel, zotarolimus) and stent designs, allowing healthcare ...
China Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-use (Hospitals, Diagnostic Centers), And Segment Forecasts, 2024 - 2030
... efficacy of the Medtronic Resolute Onyx zotarolimus-eluting coronary stent system in patients ...
|
|
|
|
